The role of ADAMTS ‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study

Author:

Obermeier Hanna L.1,Riedl Julia1,Ay Cihan1ORCID,Koder Silvia1,Quehenberger Peter2,Bartsch Rupert3,Kaider Alexandra4,Zielinski Christoph C.3,Pabinger Ingrid1

Affiliation:

1. Clinical Division of Hematology and Hemostaseology Department of Medicine I Medical University of Vienna Vienna Austria

2. Department of Medical and Chemical Laboratory Diagnostics Medical University of Vienna Vienna Austria

3. Clinical Division of Oncology Department of Medicine I Medical University of Vienna Vienna Austria

4. Section for Clinical Biometrics Center for Medical Statistics, Informatics and Intelligent Systems Medical University of Vienna Vienna Austria

Funder

Oesterreichische Nationalbank

Austrian Science Fund

Publisher

Wiley

Subject

Hematology

Reference59 articles.

1. Phlegmasia alba dolens;Trousseau A;Clin Medicale l'Hotel Dieu Paris,1865

2. Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data

3. Biomarkers for prediction of venous thromboembolism in cancer

4. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy;Di Nisio M;Cochrane Database Syst Rev,2016

5. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3